Tag: Biologics

Indian biopharmaceutical company Biocon said on Saturday it would fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary.Biocon said in a statement it will acquire the ...

Biocon Ltd is exploring the merger of biosimilars arm Biocon Biologics Ltd with itself, people aware of the development told ET. The potential deal is said to value the ...

Biocon Biologics, the subsidiary of Biocon on Saturday has received the USFDA nod to launch the biosimilar version of Janssen's Stelara (Ustekinumab) used for the treatment of autoimmune disorders ...

Expanding its footprint in the emerging markets, Biocon Biologics, an arm of biopharmaceutical company major Biocon, on Wednesday announced that it has completed the integration of the biosimilars business ...

Bengaluru: Biocon Biologics Ltd (BBL) announced that the company has completed the integration of the acquired biosimilars business in over 70 countries in Emerging Markets effective July 1, 2023, ...

New Delhi: India's Biocon Biologics closed the 12 months to end-March with revenue on a trajectory in direction of $1 billion, its CEO stated on Wednesday, helped by robust ...